AD is characterized by a long preclinical stage noted by the deposition of amyloid plaques and tau tangles, followed by a destructive cascade of neurodegeneration leading to mild cognitive impairment and progression to dementia (3, 4). The gene discussed is MAPT; the disease is Cognitive impairment.